BR9508802A - Vacinas contendo borrelia burgdorferi ospg - Google Patents

Vacinas contendo borrelia burgdorferi ospg

Info

Publication number
BR9508802A
BR9508802A BR9508802A BR9508802A BR9508802A BR 9508802 A BR9508802 A BR 9508802A BR 9508802 A BR9508802 A BR 9508802A BR 9508802 A BR9508802 A BR 9508802A BR 9508802 A BR9508802 A BR 9508802A
Authority
BR
Brazil
Prior art keywords
ospg
borrelia burgdorferi
vaccines containing
containing borrelia
vaccines
Prior art date
Application number
BR9508802A
Other languages
English (en)
Portuguese (pt)
Inventor
Reinhard Wallich
Markus M Simon
Michael F Kramer
Original Assignee
Max Planck Gesellschaft
Deutches Krebsforch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416667A external-priority patent/GB9416667D0/en
Priority claimed from GBGB9503867.5A external-priority patent/GB9503867D0/en
Application filed by Max Planck Gesellschaft, Deutches Krebsforch filed Critical Max Planck Gesellschaft
Publication of BR9508802A publication Critical patent/BR9508802A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Mycology (AREA)
BR9508802A 1994-08-17 1995-08-11 Vacinas contendo borrelia burgdorferi ospg BR9508802A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9416667A GB9416667D0 (en) 1994-08-17 1994-08-17 Vaccines and diagnostics
GBGB9503867.5A GB9503867D0 (en) 1995-02-25 1995-02-25 Vaccines and diagnostics
PCT/EP1995/003213 WO1996005313A1 (en) 1994-08-17 1995-08-11 VACCINES CONTAINING BORRELIA BURGDORFERI OspG

Publications (1)

Publication Number Publication Date
BR9508802A true BR9508802A (pt) 1997-12-30

Family

ID=26305468

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508802A BR9508802A (pt) 1994-08-17 1995-08-11 Vacinas contendo borrelia burgdorferi ospg

Country Status (12)

Country Link
EP (1) EP0781338A1 (cs)
JP (1) JPH10504455A (cs)
KR (1) KR970705636A (cs)
CN (1) CN1159831A (cs)
AU (1) AU687620B2 (cs)
BR (1) BR9508802A (cs)
CA (1) CA2197712A1 (cs)
CZ (1) CZ42497A3 (cs)
HU (1) HUT77251A (cs)
NZ (1) NZ291818A (cs)
PL (1) PL318672A1 (cs)
WO (1) WO1996005313A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632862B4 (de) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
WO2012047607A2 (en) * 2010-09-27 2012-04-12 Cornell University Methods for diagnosing lyme disease
CN111196842A (zh) * 2020-01-09 2020-05-26 济南大学 一种外膜转运通道蛋白的非跨膜结构域的表达纯化方法

Also Published As

Publication number Publication date
HUT77251A (hu) 1998-03-02
CN1159831A (zh) 1997-09-17
NZ291818A (en) 1998-09-24
KR970705636A (ko) 1997-10-09
JPH10504455A (ja) 1998-05-06
WO1996005313A1 (en) 1996-02-22
EP0781338A1 (en) 1997-07-02
CZ42497A3 (en) 1997-10-15
AU687620B2 (en) 1998-02-26
AU3345495A (en) 1996-03-07
CA2197712A1 (en) 1996-02-22
PL318672A1 (en) 1997-07-07

Similar Documents

Publication Publication Date Title
DE69313134D1 (de) Adjuvantien enthaltende impfstoffzusammensetzung
FI972034A7 (fi) Polynukleotidi tuberkuloosirokote
NO964106D0 (no) Spröyte
DE69417229D1 (de) Chirurgiegerät
DE69516621D1 (de) Chirurgischer Knotenschieber
DE69532856D1 (de) Zwischenwirbel-discuspulposus-prothese
DE19581923T1 (de) Knochenregeneration
FI962588A0 (fi) Hampaiden kiillotusaineita
ID17860A (id) Komposisi vaksin
FI941851A7 (fi) Borrelia Burgdorferi -organismin (Bb) virulenssiin liittyvät proteiini t
DE69324603D1 (de) Mikromotor
FI961565L (fi) Kanyylinpidin
ITMI942228A0 (it) Dispositivo per paraffinare
KR970705636A (ko) 보렐리아 버그도르페리(Borrelia burgdorferi) OspG를 함유하는 백신(VACCINES CONTAINING BORRELIA BURGDORFERI OSPG)
ITMI950676A0 (it) Vaccini polinucleotidici
NO970701D0 (no) Vaksiner inneholdende Borrelia burgdorferi OspG
HK1003153A (en) Vaccines containing borrelia burgdorferi ospg
IT230757Y1 (it) Cannula per fleboipodermoclisi
KR970005275A (ko) 셀프-이미지 팩(self-image pack)조성물
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
KR950013273U (ko) 목욕시 등을 미는 기구
IT230756Y1 (it) Cannula per fleboipodermoclisi
KR910016382U (ko) 굳은살 제거구
KR950022733U (ko) 세척기
KR970064203U (ko) 푸셔 유니트

Legal Events

Date Code Title Description
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law